Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ

Dow Jones
02 Apr

By WSJ Staff

Tesla $(TSLA)$: The e-vehicle maker's quarterly delivery figures are expected early Wednesday. Shares shed about 1% ahead of the open. The stock has slid this year amid a consumer backlash to Elon Musk's political activities, and tariff uncertainty.

Auto stocks: In Germany, shares of automotive supplier Continental (XE:CON) and BMW (XE:BMW) both declined. In Asia, Hyundai (KR: 005380) lost 1.2%. Ford $(F)$, General Motors $(GM)$ and Jeep maker Stellantis $(STLA)$ were little changed in U.S. premarket trading.

Global pharma stocks: Danish Ozempic maker Novo Nordisk (NVO, DK: NOVO.B) fell more than 2%. Also under pressure: Germany's Bayer (XE:BAYN), France's Sanofi (FR:SAN) and the U.K.'s GSK (U.K.:GSK, GSK). Most U.S. drug makers were little changed ahead of the bell.

Newsmax $(NMAX)$: Shares slid more than 30% premarket, continuing a rollercoaster first week of trading for the conservative TV outlet.

Grifols (ES:GRF): Private-equity firm Brookfield Asset Management (CA:BAM, BAM) has reopened takeover talks with Grifols. The pharmaceutical company's shares jumped 14% in Madrid midday trading.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

April 02, 2025 05:27 ET (09:27 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10